JulieDx
GoodRx · Director, Integrated Marketing

One messaging framework, four agencies, 15,000 subscribers.

The Situation

GoodRx was launching its first condition-based subscription products, starting with GLP-1s. High stakes, board-level attention, four agencies in motion, and a launch date that wasn't moving.

The Diagnosis

The pressure from above was to lead with big brand messaging. But nobody wakes up wanting a subscription. People wake up wanting their condition treated, and for this audience the decision came down to affordability, transparency, and convenience. Brand-first messaging would have talked past all three.

The Strategy

I built one messaging framework and held it across all four agencies, video, paid social, email, and CRM, so every asset in every channel made the same argument:

  • Transparent $39 pricing, stated plainly in every asset.
  • FDA-approved, non-compounded positioning.
  • Clarity between the subscription path and the coupon path.

The launch video and the "Dear Wrangler" social spot both carried the same line. I owned the 50-stakeholder VP-level weekly readout that kept the whole launch aligned, and the framework let every team move without waiting on me.

Frame from the GLP-1 launch video, the FDA-approved pen product shot. Click to watch the spot.
GoodRx · Video · Watch the spot
The Dear Wrangler organic social video frame.
GoodRx · Organic Social
The $39, no hidden fees paid social ad.
GoodRx · Paid Social
The GLP-1 homepage banner.
GoodRx · Homepage Banner
The GLP-1 subscription launch email.
GoodRx · Email

The Result

~15,000

The team drove about 15,000 new subscribers in the first two and a half months, on time.

The Principle

Nobody wants a subscription. They want their condition treated.